A meeting is scheduled for next week to discuss World Health Organization recommendations on marijuana, CBD and related substances.
The recommendations include removing CBD and CBD preparations containing no more than 0.2% THC from the international drug-control conventions.
The WHO’s CBD recommendation, if ultimately adopted, could lead to freer international trade in the cannabinoid.
The United Nations Commission on Narcotic Drugs Secretariat earlier this month informed all permanent missions in Vienna about the closed-door meetings June 24-25, according to an email obtained by Marijuana Business Daily.
Next week’s gathering will be the first of a series of meetings to be held before December.
That the Commission is moving ahead with the plan is a positive sign for the cannabis industry, because it indicates the organization’s commitment to hold a vote on the changes in December. The vote was delayed from March.
Read more about the WHO plan here.
